Insider Transactions in Q3 2022 at Bellicum Pharmaceuticals, Inc (BLCM)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2022
|
Judith V Klimovsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,082
+41.39%
|
-
|
|
Sep 01
2022
|
Stephen Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
43,400
+41.13%
|
-
|
|
Sep 01
2022
|
James M Daly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,082
+41.5%
|
-
|
|
Sep 01
2022
|
Reid M Huber Director |
BUY
Exercise of conversion of derivative security
|
Direct |
46,489
+41.33%
|
-
|
|
Sep 01
2022
|
Jon P Stonehouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,580
+36.88%
|
-
|